Ercros (ECR) - Total Liabilities
Based on the latest financial reports, Ercros (ECR) has total liabilities worth €485.35 Million EUR (≈ $567.42 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Ercros long-term investment allocation to see how much of total assets are deployed in long-term investments.
Ercros - Total Liabilities Trend (2000–2025)
This chart illustrates how Ercros's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see ECR asset base.
Ercros Competitors by Total Liabilities
The table below lists competitors of Ercros ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Shenzhen Wenke Landscape Co Ltd
SHE:002775
|
China | CN¥6.52 Billion |
|
Maoming Petro-Chemical Shihua Co Ltd
SHE:000637
|
China | CN¥1.40 Billion |
|
Aju IB Investment Co. Ltd
KQ:027360
|
Korea | ₩75.93 Billion |
|
Jetwell Computer Co Ltd
TWO:3147
|
Taiwan | NT$1.86 Billion |
|
Orion Engineered Carbons SA
F:0OE
|
Germany | €1.52 Billion |
|
Liuzhou Chemical Industry Co Ltd
SHG:600423
|
China | CN¥59.12 Million |
|
Agencia Comercial Spirits Ltd Class A Ordinary Shares
NASDAQ:AGCC
|
USA | $18.35 Million |
|
Yuen Foong Yu Consumer Prod
TW:6790
|
Taiwan | NT$4.66 Billion |
Liability Composition Analysis (2000–2025)
This chart breaks down Ercros's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See ECR equity financing ratio to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.98 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.71 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.63 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Ercros's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Ercros (2000–2025)
The table below shows the annual total liabilities of Ercros from 2000 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | €396.07 Million ≈ $463.05 Million |
+10.62% |
| 2024-12-31 | €358.03 Million ≈ $418.58 Million |
+11.82% |
| 2023-12-31 | €320.20 Million ≈ $374.35 Million |
-17.01% |
| 2022-12-31 | €385.84 Million ≈ $451.09 Million |
+1.98% |
| 2021-12-31 | €378.34 Million ≈ $442.32 Million |
+23.64% |
| 2020-12-31 | €306.00 Million ≈ $357.75 Million |
-16.01% |
| 2019-12-31 | €364.33 Million ≈ $425.94 Million |
+9.11% |
| 2018-12-31 | €333.90 Million ≈ $390.37 Million |
-5.06% |
| 2017-12-31 | €351.68 Million ≈ $411.15 Million |
+3.33% |
| 2016-12-31 | €340.35 Million ≈ $397.90 Million |
+1.35% |
| 2015-12-31 | €335.80 Million ≈ $392.59 Million |
-4.75% |
| 2014-12-31 | €352.53 Million ≈ $412.14 Million |
-10.09% |
| 2013-12-31 | €392.08 Million ≈ $458.38 Million |
-9.10% |
| 2012-12-31 | €431.31 Million ≈ $504.25 Million |
+3.07% |
| 2011-12-31 | €418.45 Million ≈ $489.21 Million |
-3.69% |
| 2010-12-31 | €434.46 Million ≈ $507.93 Million |
-0.06% |
| 2009-12-31 | €434.72 Million ≈ $508.23 Million |
-3.36% |
| 2008-12-31 | €449.83 Million ≈ $525.90 Million |
-7.42% |
| 2007-12-31 | €485.89 Million ≈ $568.06 Million |
-24.76% |
| 2006-12-31 | €645.81 Million ≈ $755.02 Million |
+27.14% |
| 2005-12-31 | €507.94 Million ≈ $593.84 Million |
+90.38% |
| 2004-12-31 | €266.81 Million ≈ $311.93 Million |
+18.19% |
| 2003-12-31 | €225.75 Million ≈ $263.93 Million |
+16.04% |
| 2002-12-31 | €194.55 Million ≈ $227.45 Million |
-2.32% |
| 2001-12-31 | €199.17 Million ≈ $232.85 Million |
-99.44% |
| 2000-12-31 | €35.26 Billion ≈ $41.22 Billion |
-- |
About Ercros
Ercros, S.A., together with its subsidiaries, manufactures and sells chemical and pharmaceutical products in Spain and internationally. It operates through three segments: Chlorine Derivatives, Intermediate Chemicals, and Pharmaceuticals. The company offers ammonia, caustic soda and potash, chlorine chloroisocyanurates, dichloroethane, ercrosbio, hydrochloric acid, hydrogen peroxide, polyvinyl ch… Read more